Liu, Geng
Barczak, Wojciech http://orcid.org/0000-0002-9603-2028
Lee, Lian Ni http://orcid.org/0000-0003-3915-3015
Shrestha, Amit
Provine, Nicholas M.
Albayrak, Gulsah
Zhu, Hong
Hutchings, Claire http://orcid.org/0000-0002-7858-6924
Klenerman, Paul
La Thangue, Nicholas B. http://orcid.org/0000-0003-2568-3736
Funding for this research was provided by:
Cancer Research UK (A20776)
Article History
Received: 30 March 2022
Accepted: 13 January 2023
First Online: 26 January 2023
Competing interests
: N.L.T. is a shareholder in Celleron Therapeutics Ltd. The remaining authors declare no competing interests.